Author:
Carletto A.,Cicchetti A.,Coretti S.,Moramarco V.,Ruggeri M.
Publisher
Springer Science and Business Media LLC
Subject
Economics, Econometrics and Finance (miscellaneous),General Business, Management and Accounting
Reference38 articles.
1. Adamski, J., Godman, B., Ofierska-Sujkowska, G., Osińska, B., Herholz, H., Wendykowska, K., et al. (2010). Risk sharing arrangements for pharmaceuticals: Potential considerations and recommendations for European payers. BMC Health Services Research,
10, 153.
https://doi.org/10.1186/1472-6963-10-153
.
2. Antonanzas, F., Juarez-Castello, C., & Rodriguez-Ibeas, R. (2011). Should health authorities offer risk-sharing contracts to pharmaceutical firms? A theoretical approach. Health Economics, Policy, and Law,
6(3), 391–403.
https://doi.org/10.1017/S1744133111000016
.
3. Associazione Italiana di Economia Sanitaria, gruppo di lavoro coordinato da Giovanni Fattore. (2009). Proposta di linee guida per la valutazione economica degli interventi sanitari. Politiche sanitarie,
10(2), 91–99.
4. Atella, V. (1999). Drug cost containment policies in Italy: Are they really effective in the long-run?-The case of minimum reference price. Health Policy,
50(3), 197–218.
5. Barros, P. P. (2011). The simple economics of risk-sharing agreements between the NHS and the pharmaceutical industry. Health Economics,
20(4), 461–470.
https://doi.org/10.1002/hec
.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献